Pangu
Contact
Clinical Trials
Patients
Primary Menu
Skip to content
Company
About Us
Leadership Team
Board of Directors
Advisors
Contact
Our Science
tRNA SYNTHETASE BIOLOGY
Intellectual Property
Publications, Posters and Presentations
R&D
Pipeline
Efzofitimod
Research Programs
Pangu
Patients
Clinical Trials
About Pulmonary Sarcoidosis
About SSc-ILD
Expanded Access Policy
Careers
Working at aTyr
Career Opportunities
Investors and News
News Releases
SEC Filings
Stock Information
Events and Webcasts
Investor Alerts
Corporate Governance
Analyst Coverage
ATYR0101: A New Approach to Fibrosis
American Thoracic Society Respiratory Innovation Summit, 2025
«
Anti-Fibrotic Activity Observed Across Preclinical Models of Pulmonary and Renal Fibrosis for a Potential Therapeutic Based on Asp-tRNA Synthetase
Advancing a Therapeutic Platform Based on tRNA Synthetases for Treatment of Fibrotic Lung Diseases
»
© 2007 - 2026 aTyr Pharma.
Legal
Privacy Policy
MENU
Company
About Us
Leadership Team
Board of Directors
Advisors
Contact
Our Science
Extracellular
t
RNA Synthetase Biology
Intellectual Property
Publications, Posters and Presentations
R&D
Pipeline
Efzofitimod
Research Programs
Pangu
Patients
Clinical Trials
About Pulmonary Sarcoidosis
About SSc-ILD
Expanded Access Policy
Careers
Working at aTyr
Career Opportunities
Investors and News
Corporate Governance
Board of Directors
Board Committees
News Releases
SEC Filings
Stock Information
Analyst Coverage
Investor Alerts
Events and Webcasts
Privacy Policy
